机译:纤维型普拉西亚骨质人进化临床试验的特殊考虑因素(FOP)
Division of Endocrinology and Metabolism and the Institute for Human Genetics Department of;
Unit of Rare Diseases Department of PediatricsIRCCS Giannina Gaslini InstituteGenoa Italy;
Radiant Hope Foundation and the Ian Cali FOP Research Fund PENN MedicineCenter for Research in FOP;
Departments of Orthopaedic Surgery and Genetics The Center for Research in FOP &
Related;
Division of Endocrinology Diabetes and Metabolism Departments of Medicine and Orthopaedic;
Department of MedicineMayo ClinicRochester MN USA;
Department of AnesthesiologyThomas Jefferson UniversityPhiladelphia PA USA;
Department of Internal Medicine section Endocrinology Amsterdam Bone CenterAmsterdam University;
Royal National Orthopaedic HospitalStanmore UK;
Centre de Référence Maladies Osseuses Constitutionnelles Departement de GénétiqueH?pital Necker;
Institute of Health and Biomedical Innovation Queensland University of Technology Translational;
Division of Pediatric OrthopaedicsSeoul National University Children's HospitalSeoul South Korea;
Pediatric Rheumatology Section Department of PediatricsHospital Italiano de Buenos AiresCiudad Aut;
Hospital Israelita Albert Einstein Instituto de Ensino e PesquisaS?o Paulo‐SP Brazil;
Department of Rehabilitation Medicine Graduate School of MedicineUniversity of TokyoTokyo Japan;
Department of Pediatrics Klinikum Garmisch‐Partenkirchen GmbHGarmisch‐Partenkirchen Germany;
Paediatric Rheumatology Red Cross Children's HospitalUniversity of Cape TownCape Town South Africa;
Department of Endocrinology Tongji HospitalShanghai Tongji UniversityShanghai China;
Sidney Kimmel Medical CollegeThomas Jefferson UniversityPhiladelphia PA USA;
Schulich School of Medicine and Dentistry Pediatric Oral Health and DentistryLondon ON Canada;
Departments of Medicine &
Orthopaedic Surgery Center for Research in FOP &
Related Disorders The;
Department of Internal Medicine section Endocrinology Amsterdam Bone CenterAmsterdam University;
Fibrodysplasia ossificans progressiva (FOP); patient safety; rare disease clinical trials;
机译:进行性骨增生性纤维增生症(FOP)临床试验的特殊注意事项
机译:一系列诊断为进行性骨增生性纤维化(FOP)的墨西哥患者的临床和分子分析
机译:纤维型普拉西亚的临床分期性骨质人进展(FOP)
机译:Fibrodysplasia Ossificans进展:从罕见疾病中断的见解
机译:生成诱导多能干细胞衍生的纤维型胰腺类骨质人进化患者的内皮细胞 - Activina和BMP诱导的Alk2受体激活=普通钨患者的疾病模型= Induzierten ploripotenten
机译:进行性骨增生症(FOP)临床试验的特殊考虑
机译:Activina诱导的Smad1 / 5信号在IPSC衍生的纤维素类化合物的EC模型中,可以通过药物候选Saracatinib来救出